Remove 2026 Remove Illness Remove Provider Remove Supply Chain
article thumbnail

FDA Publishes Its Draft Strategy Document on Innovative Manufacturing Technologies

FDA Law Blog

Innovative manufacturing” is a somewhat ill-defined term, but the agency uses it to refer to any novel manufacturing that can increase product development speed, bolster supply chains, or prevent drug shortages. Regarding CBER’s CATT, the center is currently revising its internal procedures, referred to as CATT 2.0,

article thumbnail

This Thanksgiving, Be Thankful for Family and Food(borne Illness Prevention)

FDA Law Blog

Gaulkin — At the risk of ruining our readers’ appetite for America’s most food-focused holiday, foodborne illnesses have been a feature of Thanksgiving for some time now. When foodborne illness outbreaks arise, efficient traceability is critical to prevent illnesses, death, and unnecessary product loss.